Dr. Candice S. Klug's lab focuses on understanding essential bacterial proteins to develop novel antibiotics against drug-resistant bacteria such as E. coli and Enterococcus faecalis. By integrating biophysical and microbiological methods with advanced electron paramagnetic resonance (EPR) spectroscopy, her research aims to provide crucial insights into protein structure and dynamics, paving the way for innovative therapeutic strategies. The lab's work not only addresses antibiotic resistance but also advances biomedical technologies for diverse applications in human health.

Dr. Francesca M. Marassi's lab focuses on understanding the biological mechanisms behind diseases associated with aging, particularly Age-Related Macular Degeneration (AMD) and Alzheimer’s Disease (AD). The team investigates the roles of calcification in these conditions and explores interactions between microbial pathogens and host defenses. This research aims to uncover new diagnostic and therapeutic strategies to combat these debilitating diseases.

Dr. Mona Al-Gizawiy's lab focuses on developing new treatments for aggressive pediatric brain tumors, specifically pediatric high-grade gliomas and atypical teratoid rhabdoid tumors. By exploring the use of gallium maltolate, a special metallocompound that mimics iron, the lab aims to inhibit tumor growth and improve survival rates for affected children while minimizing side effects. The research not only targets the cancer itself but also considers the overall quality of life of the patients.